🇺🇸 Teriparatide treatment in osteoporotic patients in United States

Teriparatide treatment in osteoporotic patients (Teriparatide treatment in osteoporotic patients) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Teriparatide treatment in osteoporotic patients in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Teriparatide treatment in osteoporotic patients approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Teriparatide treatment in osteoporotic patients in United States?

Shinshu University is the originator. The local marketing authorisation holder may differ — check the official source linked above.